azathioprine has been researched along with Paraneoplastic Syndromes in 17 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Paraneoplastic Syndromes: In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dermatomyositis is a known paraneoplastic syndrome that can complicate the course of a variety of different cancers, however, the association with HCC is extremely rare." | 5.35 | Remission of paraneoplastic dermatomyositis associated with hepatocellular carcinoma under prednisolone and azathiopin, and concommittant sorafenib. ( Apostolidis, L; Horstmann, S; Jäger, D; Kahlert, C; Lordick, F; Siegmund, A; Thom, R, 2009) |
| "Dermatomyositis is characterized by marked clinical heterogeneity." | 2.43 | [The clinical spectrum of dermatomyositis]. ( Genth, E; Hunzelmann, N; Kaufmann, J; Krieg, T, 2005) |
| "Dermatomyositis is a known paraneoplastic syndrome that can complicate the course of a variety of different cancers, however, the association with HCC is extremely rare." | 1.35 | Remission of paraneoplastic dermatomyositis associated with hepatocellular carcinoma under prednisolone and azathiopin, and concommittant sorafenib. ( Apostolidis, L; Horstmann, S; Jäger, D; Kahlert, C; Lordick, F; Siegmund, A; Thom, R, 2009) |
| "The case of a patient with fatigable diplopia and ptosis 3 years after removal of a large-cell lung carcinoma is presented." | 1.31 | Myasthenia gravis with a paraneoplastic marker. ( Leavitt, JA, 2000) |
| "The conjunctiva later became scarred with foreshortening of the fornices and development of symblepharon." | 1.28 | Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma. ( Folberg, R; Goeken, JA; Krachmer, JH; Lam, S; Massicotte, SJ; Smith, AC; Stone, MS, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apostolidis, L | 1 |
| Kahlert, C | 1 |
| Siegmund, A | 1 |
| Thom, R | 1 |
| Horstmann, S | 1 |
| Jäger, D | 1 |
| Lordick, F | 1 |
| Ferreyra, HA | 1 |
| Jayasundera, T | 1 |
| Khan, NW | 1 |
| He, S | 1 |
| Lu, Y | 1 |
| Heckenlively, JR | 1 |
| Dankó, K | 1 |
| Vincze, M | 1 |
| Frew, JW | 1 |
| Murrell, DF | 1 |
| Verrini, A | 1 |
| Cannata, G | 1 |
| Cozzani, E | 1 |
| Terracini, M | 1 |
| Parodi, A | 1 |
| Rebora, A | 1 |
| von Rainer Günther, ZB | 1 |
| Nasser, S | 1 |
| Hinrichsen, H | 1 |
| Fölsch, UR | 1 |
| Botsios, C | 1 |
| Ostuni, P | 1 |
| Boscolo-Rizzo, P | 1 |
| Da Mosto, MC | 1 |
| Punzi, L | 1 |
| Marchiori, C | 1 |
| Rossum, MM | 1 |
| Verhaegen, NT | 1 |
| Jonkman, MF | 2 |
| Mackenzie, MA | 1 |
| Koster, A | 1 |
| Van Der Valk, PG | 1 |
| Span, LF | 1 |
| Kaufmann, J | 1 |
| Hunzelmann, N | 1 |
| Genth, E | 1 |
| Krieg, T | 1 |
| Plumb, R | 1 |
| Doolittle, GC | 1 |
| Schaller, M | 1 |
| Korting, HC | 1 |
| Meurer, M | 1 |
| Schirren, CG | 1 |
| Krunic, AL | 1 |
| Kokai, D | 1 |
| Bacetic, B | 1 |
| Kesic, V | 1 |
| Nikolic, MM | 1 |
| Petkovic, S | 1 |
| Clark, RE | 1 |
| van der Waal, RI | 1 |
| Pas, HH | 1 |
| Anhalt, GJ | 1 |
| Schulten, EA | 1 |
| Nieboer, C | 1 |
| van den Berg, JS | 1 |
| van Engelen, BG | 1 |
| Boerman, RH | 1 |
| de Baets, MH | 1 |
| Leavitt, JA | 1 |
| Sieb, JP | 1 |
| Dengler, R | 1 |
| Jerusalem, F | 1 |
| Lam, S | 1 |
| Stone, MS | 1 |
| Goeken, JA | 1 |
| Massicotte, SJ | 1 |
| Smith, AC | 1 |
| Folberg, R | 1 |
| Krachmer, JH | 1 |
3 reviews available for azathioprine and Paraneoplastic Syndromes
| Article | Year |
|---|---|
[New therapeutic approaches for polymyositis and dermatomyositis].
Topics: Adrenal Cortex Hormones; Algorithms; Antineoplastic Agents; Azathioprine; Biological Therapy; Cell M | 2011 |
Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).
Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Mur | 2011 |
[The clinical spectrum of dermatomyositis].
Topics: Adult; Age Factors; Azathioprine; Biopsy; Child; Clinical Trials as Topic; Cyclophosphamide; Cyclosp | 2005 |
14 other studies available for azathioprine and Paraneoplastic Syndromes
| Article | Year |
|---|---|
Remission of paraneoplastic dermatomyositis associated with hepatocellular carcinoma under prednisolone and azathiopin, and concommittant sorafenib.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Benzenesulfonates; Carcinoma, Hepatoce | 2009 |
Management of autoimmune retinopathies with immunosuppression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Autoantigens; Autoimmune Diseases; Azath | 2009 |
A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy.
Topics: Aged; Autoantibodies; Autoantigens; Azathioprine; Cytoskeletal Proteins; Desmoplakins; Disease Progr | 2002 |
[Erythema gyratum repens. Drug hypersensitivity after azathioprine in a patient with type 1 autoimmune hepatitis].
Topics: Azathioprine; Diagnosis, Differential; Drug Eruptions; Female; Hepatitis, Autoimmune; Humans; Immuno | 2002 |
Dermatomyositis and malignancy of the pharynx in Caucasian patients: report of two observations.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Carcinoma, Squamous Cell; Combin | 2003 |
Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antig | 2004 |
Paraneoplastic pemphigus in a patient with non-Hodgkin's lymphoma.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Combined Modality Thera | 1996 |
[Generalized Mycobacterium avium-intracellulare infection due to immunosuppressive therapy of paraneoplastic dermatomyositis].
Topics: Adenocarcinoma; Azathioprine; Biopsy; Breast Neoplasms; Dermatomyositis; Female; Fluocortolone; Huma | 1997 |
Retroperitoneal round-cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoides-like eruption.
Topics: Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Azathioprine; Diagnosis, Differential; Fe | 1997 |
Paraneoplastic pemphigus as the presenting symptom of a lymphoma of the tongue.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Cyclop | 1998 |
Acquired neuromyotonia: superiority of plasma exchange over high-dose intravenous human immunoglobulin.
Topics: Anti-Inflammatory Agents; Azathioprine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agen | 1999 |
Myasthenia gravis with a paraneoplastic marker.
Topics: Autoantibodies; Azathioprine; Biomarkers; Blepharoptosis; Calcium Channels; Carcinoma, Large Cell; D | 2000 |
[Non-neoplastic Lambert-Eaton syndrome. A frequently missed diagnosis?].
Topics: Adult; Azathioprine; Diagnosis, Differential; Electric Stimulation; Female; Humans; Lambert-Eaton My | 1992 |
Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma.
Topics: Acanthosis Nigricans; Aged; Azathioprine; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Chronic | 1992 |